logo

Regeneron Pharmaceuticals (REGN)



Trade REGN now with
  Date
  Headline
2/21/2018 2:13:50 PM Canaccord Is Cutting Regeneron Pharmaceuticals (REGN) 2018 Estimate To 15.65 From 15.70
2/21/2018 2:12:56 PM Canaccord Is Cutting Regeneron Pharmaceuticals (REGN) 2018 Rev. Estimate To 6.237 Billion From 6.250 Billion
2/21/2018 2:11:27 PM Canaccord Downgrades Regeneron Pharmaceuticals (REGN) To Hold From Buy With $356 Down From $522 Price Target
2/21/2018 11:11:36 AM Regeneron Downgraded At Canaccord
2/12/2018 7:01:02 AM Regeneron Announces Appointment Of Marion McCourt As SVPand Head Of Commercial
2/8/2018 6:32:41 AM Regeneron Q4 GAAP EPS $1.50 Vs $2.19 Last Year
1/22/2018 7:01:25 AM Regeneron Announces Approval Of DUPIXENT In Japan For Atopic Dermatitis
1/8/2018 7:02:38 AM Sanofi, Regeneron To Accelerate, Expand Investment For Cemiplimab And Dupilumab Development Programs
12/29/2017 11:15:43 AM Regeneron Maintained As Outperform At Evercore ISI
12/18/2017 1:00:44 AM Regeneron And ISA Pharmaceuticals Announce Strategic Immuno-Oncology Collaboration
12/13/2017 1:02:58 AM Regeneron, Sanofi Report Positive Topline Pivotal Results For PD-1 Antibody Cemiplimab In Advanced CSCC
12/11/2017 7:01:42 AM Regeneron Announces FDA Acceptance Of SBLA Filing For 12-Week Dosing Of EYLEA Injection For Patients With Wet AMD